Translational Cancer Observational Protocol
2014 Transizionali - Observational Study on the Occurrence of Relapses and on the Quality of Life in Patients Who Underwent Nephroureterectomy Surgery
1 other identifier
observational
1,250
1 country
1
Brief Summary
Observational study on relapse occurrence and on the quality of life in patients who underwent nephroureterectomy surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2014
CompletedFirst Submitted
Initial submission to the registry
November 23, 2023
CompletedFirst Posted
Study publicly available on registry
December 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 17, 2064
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 17, 2064
December 13, 2023
December 1, 2023
50 years
November 23, 2023
December 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical progression data collection
Collection intended for the purpose of implementing diagnostic and therepautic strategies for the management of the disease in both the patient enrolled in the study and for future cases. Data will be collected in a dedicated internal database by means of medical records obtained during the patients' stay in the hospital and during follow up visits. The data collected includes anamnesis, data regarding surgery, laboratory exam and imaging exams.
50 years
Study Arms (1)
Experimental
Patients with upper urinary tract urothelial cancer who underwent nephroureterectomy surgery
Interventions
Removal of cancer mass by urether and kidney complete resection.
Eligibility Criteria
Patients with upper tract urothelial cancer who underwent nephroureterectomy surgery.
You may qualify if:
- years or older
- Upper tract urothelial cancer diagnosis
- Indication to cancer removal through nephroureterectomy surgery
- Ability to read and sign the informed consent
You may not qualify if:
- Age \< 18 years
- Absence of upper tract urothelial cancer
- Inability to read and sign the informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Ospedale San Raffaele
Milan, MI, 20132, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francesco Montorsi, MD
IRCCS Ospedale San Raffaele
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 23, 2023
First Posted
December 13, 2023
Study Start
July 17, 2014
Primary Completion (Estimated)
July 17, 2064
Study Completion (Estimated)
July 17, 2064
Last Updated
December 13, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share